These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 877570)

  • 1. L-dopa: selective toxicity for melanoma cells in vitro.
    Wick MM; Byers L; Frei E
    Science; 1977 Jul; 197(4302):468-9. PubMed ID: 877570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro.
    Wick MM; Frei E
    Cancer Res; 1977 Jul; 37(7 Pt 1):2123-5. PubMed ID: 861938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo.
    Fujita K; Ito S; Inoue S; Yamamoto Y; Takeuchi J; Shamoto M; Nagatsu T
    Cancer Res; 1980 Jul; 40(7):2543-6. PubMed ID: 6771000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective toxicity of 6-hydroxydopa for melanoma cells.
    Wick MM; Byers L; Ratliff J
    J Invest Dermatol; 1979 Feb; 72(2):67-9. PubMed ID: 422870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells.
    Kable EP; Parsons PG
    Cancer Chemother Pharmacol; 1989; 23(1):1-7. PubMed ID: 2909284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of L-dopa on the growth of human melanoma cells in vitro.
    Osman AM; Amer TM
    J Pharm Belg; 1987; 42(5):323-6. PubMed ID: 3430331
    [No Abstract]   [Full Text] [Related]  

  • 7. The cytotoxicity of cysteinylcatechols and related compounds to human melanoma cells in vitro.
    Yamada I; Seki S; Matsubara O; Ito S; Suzuki S; Kasuga T
    J Invest Dermatol; 1987 May; 88(5):538-40. PubMed ID: 3572026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopamine agonists and antagonists on murine melanoma: correlation with dopamine binding activity.
    Krummel TM; Neifeld JP; Taub RN
    Cancer; 1982 Mar; 49(6):1178-84. PubMed ID: 7059943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment effects on the uptake/retention kinetics of L-dopa in Harding-Passey melanoma.
    Berjian RA; Kanter PM; Bhakoo HS; Tan MH; Lawrence DD
    J Invest Dermatol; 1986 May; 86(5):560-2. PubMed ID: 3745966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic amines are selective cytotoxic agents for pigmented cells.
    Noga EJ; Barthalmus GT; Mitchell MK
    Cell Biol Int Rep; 1986 Apr; 10(4):239-47. PubMed ID: 3708699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of L-dopa incorporation into melanoma by dopa decarboxylase inhibition.
    Wick MM; Kramer RA; Gorman M
    J Invest Dermatol; 1978 Jun; 70(6):358-60. PubMed ID: 649984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance.
    Silagi S
    J Cell Biol; 1969 Nov; 43(2):263-74. PubMed ID: 4981070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP; Favier D; Parsons PG
    Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation by L-dopa of growth inhibition and melanin formation of X-irradiated Harding-Passey melanoma cells in culture.
    Schachtschabel DO; Pfab R; Paul N; Hess F
    Strahlenther Onkol; 1988 Jul; 164(7):419-24. PubMed ID: 3400051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoacids--precursors of melanin synthesis in hamster melanoma.
    Blagoeva PM
    J Cancer Res Clin Oncol; 1984; 108(3):366-8. PubMed ID: 6511810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo-related pigment cell differentiation antigens are expressed on malignant melanoma cells following phenotypic reversion induced by contact inhibitory factor.
    Lipkin G; Naughton GK; Rosenberg M; Bystryn JC
    Differentiation; 1985; 30(1):35-9. PubMed ID: 3912244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of L-dopa on the potentiation of radiation damage to human melanoma cells.
    Yamada I; Seki S; Ito S; Suzuki S; Matsubara O; Kasuga T
    Br J Cancer; 1990 Jul; 62(1):33-6. PubMed ID: 2390479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-DOPA is an endogenous ligand for OA1.
    Lopez VM; Decatur CL; Stamer WD; Lynch RM; McKay BS
    PLoS Biol; 2008 Sep; 6(9):e236. PubMed ID: 18828673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigmented hyperplasia of epidermis following feeding of L-dopa to elderly rats.
    Maat B
    J Natl Cancer Inst; 1977 May; 58(5):1433-6. PubMed ID: 853529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic characterization of three hamster melanoma variants.
    Scisłowski PW; Słomiński A; Bomirski A; Zydowo M
    Neoplasma; 1985; 32(5):593-8. PubMed ID: 4069292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.